Cytokinetics's total assets for Q1 2025 were $1.26B, a decrease of -9.82% from the previous quarter. CYTK total liabilities were $1.53B for the fiscal quarter, a -0.43% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.